Bio Protocol CEO Paul Kohlhaas unpacked the concept of DeSci and explained how his firm is looking to upend science funding.
Bio Protocol CEO Paul Kohlhaas unpacked the concept of DeSci and explained how his firm is looking to upend science funding.